TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent ex vivo anti-myeloma activity

Affiliations

¹ T-E Meds, Inc., Taipei.
² Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City.
³ Immunwork, Inc., Taipei.
⁴ T-E Meds, Inc., Taipei, Taiwan; Immunwork, Inc., Taipei.
⁵ T-E Meds, Inc., Taipei, Taiwan; Immunwork, Inc., Taipei. carmaylim0830@gmail.com.
⁶ Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan. fishie.yu@gmail.com.

Free article

Shih-Syuan Cheng et al. Haematologica. 2025.

Free article

. 2025 Nov 6.

doi: 10.3324/haematol.2025.288692. Online ahead of print.

¹ T-E Meds, Inc., Taipei.
² Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City.
³ Immunwork, Inc., Taipei.
⁴ T-E Meds, Inc., Taipei, Taiwan; Immunwork, Inc., Taipei.
⁵ T-E Meds, Inc., Taipei, Taiwan; Immunwork, Inc., Taipei. carmaylim0830@gmail.com.
⁶ Department of Medicine, Division of Hematology and Oncology, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Graduate Institute of Medicine, Yuan Ze University, Taoyuan. fishie.yu@gmail.com.

Abstract

Not available.